Investigators at Montreal's Lady Davis Institute at the Jewish General Hospital and McGill University Health Centre have announced the start of a landmark clinical study aimed at restoring normal insulin secretion in people with longstanding type 1 diabetes. The treatment combines INGAP Peptide (ExsulinTM), which stimulates growth of the insulin secreting islets, and ustekinumab (SteleraTM), a drug approved for the treatment of psoriasis.
The Basque Institute of Agricultural Research and Development Neiker Tecnalia has tested the effectiveness of an innovative system to estimate vegetative growth in vines by measuring the infrared radiation emission of the plants. The method is known as the Normalized Difference Vegetation Index and estimates the vegetative growth of plants by measuring the solar radiation that plants reflect in the red and near-infrared band of the electromagnetic spectrum.
The University of Southampton is to play a major role in a new national center that will grow and transform the UK's major infrastructure sectors including transport, energy systems, clean water supplies, waste management and flood defenses.
Rice scientists are in place for the next round of discovery at the Large Hadron Collider, which began its first run of heavy-ion collisions in three years this week. The team hopes to learn how quarks and gluons behaved in the microseconds after the Big Bang.
Scientists and computer engineers at the University of Southampton have developed an interactive climate app -- CO2 Modeller -- which can fit in your pocket and help you to gauge the future effects of carbon emissions around key sensitivities of the Earth's climate. The new app, CO2 Modeller, provides an interactive tool to allow anyone -- from members of the public to policy makers -- to explore for themselves the implications of delaying emission reductions on their tablet or smartphone.
VTT Technical Research Centre of Finland Ltd, under the INNO-SOFC project and in collaboration with Convion Ltd and Elcogen Ltd, is developing a new-generation, long-life fuel cell system offering efficiency higher than that of competing technologies.
Scientists from Nanyang Technological University have developed a smart chip which can tell you how healthy is your battery and if it is safe for use.
A new drug combination may be effective in treating men with metastatic prostate cancer. Preliminary results of this new approach are encouraging and have led to an ongoing international study being conducted in 196 hospitals worldwide.
As part of the United Arab Emirates University's ambitious vision and in response to the directives of His Excellency Sheikh Hamdan Bin Mubarak Al Nahyan, Chancellor of UAEU, the Intellectual Property and Transfer of Technology Office from the Department of the Deputy Vice Chancellor for Research and Graduate Studies, organized a symposium on Intellectual Property and the Transfer of Technology on Monday, Nov. 23, 2015.
An experimental vaccine to protect against the mosquito-borne illness chikungunya is being tested in a Phase 2 trial sponsored by the National Institutes of Health. Results from an initial trial of the vaccine were reported in 2014. In that study, all 25 vaccine recipients developed robust immune responses and no safety concerns were noted. The new trial is will enroll 400 healthy adult volunteers aged 18 to 60 years old at six sites in the Caribbean.